FDA Inspection 1029411 — Tandem Diabetes Care, INC.
The FDA completed an inspection of Tandem Diabetes Care, INC. on September 29, 2017 in San Diego, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- September 29, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- San Diego, CA (United States)